Literature DB >> 8162574

Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer.

A Merlo1, E Gabrielson, M Mabry, R Vollmer, S B Baylin, D Sidransky.   

Abstract

We analyzed the pattern of allelic loss in 33 primary human small cell lung cancers (SCLCs) using highly informative microsatellite markers on chromosomes 2p, 3p, 5q, 6, 9, 13q, and 17p. Nineteen of these tumors (58%) displayed loss of heterozygosity on chromosome 9. Fourteen SCLCs demonstrated loss of heterozygosity for all informative markers on both chromosomal arms; two tumors demonstrated partial loss on chromosome 9p. In one tumor, a multiplex polymerase chain reaction assay disclosed a homozygous deletion at 9p21-22 including the markers IFN-alpha, D9S126, and D9S171. Two SCLCs retained all informative markers on 9p but showed allelic loss of the entire 9q arm, while one case had a partial loss of proximal 9q extending into all of 9p. Analysis of other chromosomal arms showed loss of heterozygosity on 3p (93%), 5q (75%), 6p (46%), 6q (47%), 13q (75%), and 17p (93%). It was necessary to test multiple markers at several loci because of the frequent expression of microsatellite instability that confounded our mapping efforts in SCLCs with replication errors. This study demonstrates the frequent loss of a suppressor gene locus on chromosome 9p21-22 and identifies novel suppressor loci on 6p, 6q, and 9q in primary SCLC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8162574

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  The antidote effect of quinone oxidoreductase 2 inhibitor against paraquat-induced toxicity in vitro and in vivo.

Authors:  Elzbieta Janda; Maddalena Parafati; Serafina Aprigliano; Cristina Carresi; Valeria Visalli; Iolanda Sacco; Domenica Ventrice; Tiziana Mega; Nuria Vadalá; Stefano Rinaldi; Vincenzo Musolino; Ernesto Palma; Santo Gratteri; Domenicantonio Rotiroti; Vincenzo Mollace
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

2.  Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.

Authors:  S F Huang; S Xiao; A A Renshaw; K R Loughlin; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Parkin gene alterations in ovarian carcinoma from northern Indian population.

Authors:  Syed Jafar Mehdi; Asgar Ali; M Moshahid Alam Rizvi
Journal:  Pathol Oncol Res       Date:  2011-01-10       Impact factor: 3.201

4.  Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.

Authors:  S J Mehdi; M S Alam; S Batra; M M A Rizvi
Journal:  Med Oncol       Date:  2010-07-22       Impact factor: 3.064

5.  Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice.

Authors:  J K Lander; H Fan
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Regulation of human methylthioadenosine phosphorylase gene by the CBF (CCAAT binding factor)/NF-Y (nuclear factor-Y).

Authors:  Yuwaraj Kadariya; Kaname Nakatani; Junji Nishioka; Takahiko Fujikawa; Warren D Kruger; Tsutomu Nobori
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

Review 7.  Hepatocarcinogenesis in rodents and humans.

Authors:  T Kitagawa; K Miyasaka; H Kanda; H Yasui; O Hino
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

8.  A major lung cancer susceptibility locus maps to chromosome 6q23-25.

Authors:  J E Bailey-Wilson; C I Amos; S M Pinney; G M Petersen; M de Andrade; J S Wiest; P Fain; A G Schwartz; M You; W Franklin; C Klein; A Gazdar; H Rothschild; D Mandal; T Coons; J Slusser; J Lee; C Gaba; E Kupert; A Perez; X Zhou; D Zeng; Q Liu; Q Zhang; D Seminara; J Minna; M W Anderson
Journal:  Am J Hum Genet       Date:  2004-07-21       Impact factor: 11.025

9.  Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.

Authors:  V G Gorgoulis; P Zacharatos; A Kotsinas; T Liloglou; A Kyroudi; M Veslemes; A Rassidakis; T D Halazonetis; J K Field; C Kittas
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

10.  Loss of heterozygosity on chromosomes 3p,8p,9p and 17p in the progression of squamous cell carcinoma of the larynx.

Authors:  Woo Jeong Yoo; Seung Ho Cho; Youn Soo Lee; Gyeong Sin Park; Min Sik Kim; Byung Kee Kim; Won Sang Park; Jung Yong Lee; Chang Suk Kang
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.